Chris Paradise

Company: Rion

Job title: Vice President - Research & Development

Bio:

Chris Paradise serves as Vice President of Research and Development at Rion, Inc., a clinical-stage biotechnology company leveraging the regenerative capacity of platelet-derived extracellular vesicles to provide cell-free regenerative therapies. Chris has been involved in the translation of Rion’s extracellular vesicle therapeutic from its origins within academia to a clinical-stage Drug Product. Chris received a Ph.D. in Biomedical Sciences with an emphasis in Regenerative Medicine from the Mayo Clinic Graduate School of Biomedical Sciences. He has contributed to over 50 publications within the field of Regenerative Medicine and remains active in the academic community.

Seminars:

Clinical Application of Platelet-Derived Exosomes in Regenerative Medicine 8:30 am

Introduction to Rion’s exosome-based drug product and MOA Current application of Rion’s technology in clinical trials Forward-looking application of platelet-derived exosomes NEW DATA!Read more

day: Conference Day One